FDA
is clarifying dosing and warning recommendations for the antidepressant Celexa (citalopram hydrobromide; also available in
generic form). In August 2011, FDA issued a Drug Safety Communication
(DSC) stating that citalopram should no longer be used at doses greater than 40
mg per day because it could cause potentially dangerous abnormalities in the
electrical activity of the heart. Citalopram use at any dose is
discouraged in patients with certain conditions because of the risk of QT
prolongation, but because it may be important for some of those patients to use
citalopram, the drug label has been changed to describe the particular caution
that needs to be taken when citalopram is used in such patients. The revised
drug label also describes lower doses that should be used in patients over 60
years of age.
No comments:
Post a Comment